Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea.
van den Anker-Lugtenburg
P J
PJ
Sizoo
W
W
D000208:Acute Disease; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D007938:Leukemia / Q000139:chemically induced / Q000209:etiology*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000209:etiology*; D013920:Thrombocythemia, Essential / Q000150:complications / Q000188:drug therapy*
D006918:Hydroxyurea